Advertisement

Antiemetika und Antivertiginosa

  • Karl-Friedrich Hamann

Zusammenfassung

Antiemetika und Antivertiginosa werden zur Behandlung von Erbrechen und Schwindel eingesetzt. Der weitaus größte Teil der Verordnungen entfällt auf Betahistin für Patienten mit Morbus Menière. Schwerpunkt der H1-Antihistaminika sind Prophylaxe und symptomatische Therapie von Übelkeit und Erbrechen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baloh RW (2003): Clinical practice. Vestibular neuritis. N Engl J Med 348: 1027–1032.PubMedCrossRefGoogle Scholar
  2. Billio A, Morello E, Clarke MJ (2010): Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD00627–2.Google Scholar
  3. Brandt T, Dichgans J, Diener HC (Hrsg) (1998): Therapie und Verlauf neurologischer Erkrankungen. 3. Aufl, Verlag Kohlhammer, Stuttgart Berlin Köln S. 127–156.Google Scholar
  4. Hamann K-F, Arnold W (1999): Menière's disease. In: Büttner U (ed): Vestibular dysfunction and its therapy. Adv ORL 55: 137–168.Google Scholar
  5. Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M, Canis M (2012): Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS One 7: e3908–6Google Scholar
  6. James A, Burton MJ (2009): Betahistine for Ménière's disease or syndrome. Cochrane Database of Systematic Reviews 2001, Issue 1. Publication status and date: Edited (no change to conclusions), published in Issue 1, 2009. Art. No.: CD001873. DOI: 10.1002/14651858. CD001873.PubMedCentralPubMedGoogle Scholar
  7. Kranke P, Morin AM, Roewer N, Eberhart LH (2002): Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand 46: 238–244.PubMedCrossRefGoogle Scholar
  8. Lacour M, van de Heyning PH, Novotny M, Tighilet B (2007): Betahistine in the treatment of Ménière's disease. Neuropsychiatr Dis Treat 3: 441–453.Google Scholar
  9. Molino A, Guglielmo L, Azzolini ME, Biondani P, Capelli MC, Grandinetti A, Griso C, Martinelli G, Martini N, Zanotti R, et al. (1991): The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. Oncology 48: 111–115.PubMedGoogle Scholar
  10. Spinks AB, Wasiak J, Villanueva EV, Bernath V (2007): Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD00285–1.Google Scholar
  11. Strupp M, Brandt T (2013): Peripheral vestibular disorders. Curr Opin Neurol 26: 81-89.Google Scholar
  12. Westhofen M (2009): M. Menière. Evidenzen und Kontroversen. HNO 57: 446–454.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Karl-Friedrich Hamann
    • 1
  1. 1.München

Personalised recommendations